The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Andrographis Paniculata Medicine Market Research Report 2025
Synopsis
The global Andrographis Paniculata Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Clinical needs: Andrographis paniculata has the functions of clearing heat, detoxifying, reducing inflammation, reducing swelling and relieving pain. It has a wide range of clinical applications, especially in the treatment of respiratory diseases such as colds, coughs, pharyngitis, and pneumonia. As the incidence of these diseases increases, the clinical demand for Andrographis paniculata drugs continues to increase, promoting the development of Andrographis paniculata drugs.
This report aims to provide a comprehensive presentation of the global market for Andrographis Paniculata Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographis Paniculata Medicine.
Report Scope
The Andrographis Paniculata Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Andrographis Paniculata Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographis Paniculata Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tasly Group
Baiyunshan Pharmaceutical
Tongrentang
Changchun People Pharmaceutical
Wantong Pharmaceutical
Yiling Pharmaceutical
Shibiao Pharmaceutical
Sunflower Pharmaceutical
CSPC Pharmaceutical Group
Nuojin Pharmaceutical
ECHENG
Renhe Pharmaceutical
Furen Pharmaceutical
Jiuhui Pharmaceutical
Segment by Type
Tablet
Pill
Capsule
Segment by Application
Hospital Clinic
Brick and Mortar Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographis Paniculata Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographis Paniculata Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Andrographis Paniculata Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Clinical needs: Andrographis paniculata has the functions of clearing heat, detoxifying, reducing inflammation, reducing swelling and relieving pain. It has a wide range of clinical applications, especially in the treatment of respiratory diseases such as colds, coughs, pharyngitis, and pneumonia. As the incidence of these diseases increases, the clinical demand for Andrographis paniculata drugs continues to increase, promoting the development of Andrographis paniculata drugs.
This report aims to provide a comprehensive presentation of the global market for Andrographis Paniculata Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographis Paniculata Medicine.
Report Scope
The Andrographis Paniculata Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Andrographis Paniculata Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographis Paniculata Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Tasly Group
Baiyunshan Pharmaceutical
Tongrentang
Changchun People Pharmaceutical
Wantong Pharmaceutical
Yiling Pharmaceutical
Shibiao Pharmaceutical
Sunflower Pharmaceutical
CSPC Pharmaceutical Group
Nuojin Pharmaceutical
ECHENG
Renhe Pharmaceutical
Furen Pharmaceutical
Jiuhui Pharmaceutical
Segment by Type
Tablet
Pill
Capsule
Segment by Application
Hospital Clinic
Brick and Mortar Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographis Paniculata Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographis Paniculata Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Andrographis Paniculata Medicine Market Overview
1.1 Product Overview and Scope of Andrographis Paniculata Medicine
1.2 Andrographis Paniculata Medicine Segment by Type
1.2.1 Global Andrographis Paniculata Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Pill
1.2.4 Capsule
1.3 Andrographis Paniculata Medicine Segment by Application
1.3.1 Global Andrographis Paniculata Medicine Market Value by Application: (2024-2030)
1.3.2 Hospital Clinic
1.3.3 Brick and Mortar Pharmacy
1.3.4 Online Pharmacy
1.4 Global Andrographis Paniculata Medicine Market Size Estimates and Forecasts
1.4.1 Global Andrographis Paniculata Medicine Revenue 2019-2030
1.4.2 Global Andrographis Paniculata Medicine Sales 2019-2030
1.4.3 Global Andrographis Paniculata Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Andrographis Paniculata Medicine Market Competition by Manufacturers
2.1 Global Andrographis Paniculata Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Andrographis Paniculata Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Andrographis Paniculata Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Andrographis Paniculata Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Andrographis Paniculata Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Andrographis Paniculata Medicine, Product Type & Application
2.7 Andrographis Paniculata Medicine Market Competitive Situation and Trends
2.7.1 Andrographis Paniculata Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Andrographis Paniculata Medicine Players Market Share by Revenue
2.7.3 Global Andrographis Paniculata Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Andrographis Paniculata Medicine Retrospective Market Scenario by Region
3.1 Global Andrographis Paniculata Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Andrographis Paniculata Medicine Global Andrographis Paniculata Medicine Sales by Region: 2019-2030
3.2.1 Global Andrographis Paniculata Medicine Sales by Region: 2019-2024
3.2.2 Global Andrographis Paniculata Medicine Sales by Region: 2025-2030
3.3 Global Andrographis Paniculata Medicine Global Andrographis Paniculata Medicine Revenue by Region: 2019-2030
3.3.1 Global Andrographis Paniculata Medicine Revenue by Region: 2019-2024
3.3.2 Global Andrographis Paniculata Medicine Revenue by Region: 2025-2030
3.4 North America Andrographis Paniculata Medicine Market Facts & Figures by Country
3.4.1 North America Andrographis Paniculata Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Andrographis Paniculata Medicine Sales by Country (2019-2030)
3.4.3 North America Andrographis Paniculata Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographis Paniculata Medicine Market Facts & Figures by Country
3.5.1 Europe Andrographis Paniculata Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Andrographis Paniculata Medicine Sales by Country (2019-2030)
3.5.3 Europe Andrographis Paniculata Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographis Paniculata Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Andrographis Paniculata Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Andrographis Paniculata Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Andrographis Paniculata Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Andrographis Paniculata Medicine Market Facts & Figures by Country
3.7.1 Latin America Andrographis Paniculata Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Andrographis Paniculata Medicine Sales by Country (2019-2030)
3.7.3 Latin America Andrographis Paniculata Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Andrographis Paniculata Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographis Paniculata Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Andrographis Paniculata Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Andrographis Paniculata Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographis Paniculata Medicine Sales by Type (2019-2030)
4.1.1 Global Andrographis Paniculata Medicine Sales by Type (2019-2024)
4.1.2 Global Andrographis Paniculata Medicine Sales by Type (2025-2030)
4.1.3 Global Andrographis Paniculata Medicine Sales Market Share by Type (2019-2030)
4.2 Global Andrographis Paniculata Medicine Revenue by Type (2019-2030)
4.2.1 Global Andrographis Paniculata Medicine Revenue by Type (2019-2024)
4.2.2 Global Andrographis Paniculata Medicine Revenue by Type (2025-2030)
4.2.3 Global Andrographis Paniculata Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Andrographis Paniculata Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Andrographis Paniculata Medicine Sales by Application (2019-2030)
5.1.1 Global Andrographis Paniculata Medicine Sales by Application (2019-2024)
5.1.2 Global Andrographis Paniculata Medicine Sales by Application (2025-2030)
5.1.3 Global Andrographis Paniculata Medicine Sales Market Share by Application (2019-2030)
5.2 Global Andrographis Paniculata Medicine Revenue by Application (2019-2030)
5.2.1 Global Andrographis Paniculata Medicine Revenue by Application (2019-2024)
5.2.2 Global Andrographis Paniculata Medicine Revenue by Application (2025-2030)
5.2.3 Global Andrographis Paniculata Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Andrographis Paniculata Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Tasly Group
6.1.1 Tasly Group Corporation Information
6.1.2 Tasly Group Description and Business Overview
6.1.3 Tasly Group Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Tasly Group Andrographis Paniculata Medicine Product Portfolio
6.1.5 Tasly Group Recent Developments/Updates
6.2 Baiyunshan Pharmaceutical
6.2.1 Baiyunshan Pharmaceutical Corporation Information
6.2.2 Baiyunshan Pharmaceutical Description and Business Overview
6.2.3 Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.2.5 Baiyunshan Pharmaceutical Recent Developments/Updates
6.3 Tongrentang
6.3.1 Tongrentang Corporation Information
6.3.2 Tongrentang Description and Business Overview
6.3.3 Tongrentang Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tongrentang Andrographis Paniculata Medicine Product Portfolio
6.3.5 Tongrentang Recent Developments/Updates
6.4 Changchun People Pharmaceutical
6.4.1 Changchun People Pharmaceutical Corporation Information
6.4.2 Changchun People Pharmaceutical Description and Business Overview
6.4.3 Changchun People Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changchun People Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.4.5 Changchun People Pharmaceutical Recent Developments/Updates
6.5 Wantong Pharmaceutical
6.5.1 Wantong Pharmaceutical Corporation Information
6.5.2 Wantong Pharmaceutical Description and Business Overview
6.5.3 Wantong Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wantong Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.5.5 Wantong Pharmaceutical Recent Developments/Updates
6.6 Yiling Pharmaceutical
6.6.1 Yiling Pharmaceutical Corporation Information
6.6.2 Yiling Pharmaceutical Description and Business Overview
6.6.3 Yiling Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yiling Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.6.5 Yiling Pharmaceutical Recent Developments/Updates
6.7 Shibiao Pharmaceutical
6.6.1 Shibiao Pharmaceutical Corporation Information
6.6.2 Shibiao Pharmaceutical Description and Business Overview
6.6.3 Shibiao Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shibiao Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.7.5 Shibiao Pharmaceutical Recent Developments/Updates
6.8 Sunflower Pharmaceutical
6.8.1 Sunflower Pharmaceutical Corporation Information
6.8.2 Sunflower Pharmaceutical Description and Business Overview
6.8.3 Sunflower Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sunflower Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.8.5 Sunflower Pharmaceutical Recent Developments/Updates
6.9 CSPC Pharmaceutical Group
6.9.1 CSPC Pharmaceutical Group Corporation Information
6.9.2 CSPC Pharmaceutical Group Description and Business Overview
6.9.3 CSPC Pharmaceutical Group Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSPC Pharmaceutical Group Andrographis Paniculata Medicine Product Portfolio
6.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.10 Nuojin Pharmaceutical
6.10.1 Nuojin Pharmaceutical Corporation Information
6.10.2 Nuojin Pharmaceutical Description and Business Overview
6.10.3 Nuojin Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nuojin Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.10.5 Nuojin Pharmaceutical Recent Developments/Updates
6.11 ECHENG
6.11.1 ECHENG Corporation Information
6.11.2 ECHENG Andrographis Paniculata Medicine Description and Business Overview
6.11.3 ECHENG Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ECHENG Andrographis Paniculata Medicine Product Portfolio
6.11.5 ECHENG Recent Developments/Updates
6.12 Renhe Pharmaceutical
6.12.1 Renhe Pharmaceutical Corporation Information
6.12.2 Renhe Pharmaceutical Andrographis Paniculata Medicine Description and Business Overview
6.12.3 Renhe Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Renhe Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.12.5 Renhe Pharmaceutical Recent Developments/Updates
6.13 Furen Pharmaceutical
6.13.1 Furen Pharmaceutical Corporation Information
6.13.2 Furen Pharmaceutical Andrographis Paniculata Medicine Description and Business Overview
6.13.3 Furen Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Furen Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.13.5 Furen Pharmaceutical Recent Developments/Updates
6.14 Jiuhui Pharmaceutical
6.14.1 Jiuhui Pharmaceutical Corporation Information
6.14.2 Jiuhui Pharmaceutical Andrographis Paniculata Medicine Description and Business Overview
6.14.3 Jiuhui Pharmaceutical Andrographis Paniculata Medicine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jiuhui Pharmaceutical Andrographis Paniculata Medicine Product Portfolio
6.14.5 Jiuhui Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographis Paniculata Medicine Industry Chain Analysis
7.2 Andrographis Paniculata Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographis Paniculata Medicine Production Mode & Process
7.4 Andrographis Paniculata Medicine Sales and Marketing
7.4.1 Andrographis Paniculata Medicine Sales Channels
7.4.2 Andrographis Paniculata Medicine Distributors
7.5 Andrographis Paniculata Medicine Customers
8 Andrographis Paniculata Medicine Market Dynamics
8.1 Andrographis Paniculata Medicine Industry Trends
8.2 Andrographis Paniculata Medicine Market Drivers
8.3 Andrographis Paniculata Medicine Market Challenges
8.4 Andrographis Paniculata Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
